)

Neola Medical (NEOLA) investor relations material
Neola Medical Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Achieved key clinical milestones, including initiation and first patient enrollment in the Swedish pilot study and IRB approval with agreement at Cooper Hospital for the pivotal U.S. clinical study, advancing the regulatory pathway toward FDA market authorization.
Strengthened international patent portfolio with new patents granted in China and Europe, reinforcing core technology protection for continuous lung monitoring.
Secured approximately SEK 20 million in financing through a directed share issue, attracting new institutional investors and supporting clinical development.
Recognized as a finalist for Sweden's Pioneer Prize and selected to participate in World Expo 2025, enhancing global visibility.
Financial highlights
Operating revenue for H1 2025 was SEK 4,381k, down from SEK 6,208k year-over-year; Q2 2025 revenue was SEK 2,219k.
Operating result for H1 2025 was SEK -5,740k (H1 2024: -5,579k); Q2 2025 result was SEK -3,028k.
Cash and cash equivalents at June 30, 2025, were SEK 26,513k, with no interest-bearing debt and a high equity ratio of 95%.
Operational costs for H1 2025 were slightly lower year-over-year due to reduced need for external resources.
Majority of costs for ongoing studies are expected to occur later in 2025.
Outlook and guidance
Pivotal U.S. clinical study expected to begin after completion of the Swedish pilot study, with both U.S. sites targeted to start simultaneously.
FDA and CE mark submissions planned for 2026, with approvals expected in 2026/2027.
Focus remains on clinical validation, regulatory progress, and market launch preparations, especially in the U.S.
Burn rate expected to increase as clinical validation accelerates and commercial structure preparations progress.
Ongoing efforts to expand hospital relationships and prepare for adoption in top U.S. children's hospitals.
Next Neola Medical earnings date

Next Neola Medical earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage